Last reviewed · How we verify
Blood samples for PK
Blood samples for PK is a Biologic drug developed by Centre Hospitalier Universitaire de Saint Etienne. It is currently FDA-approved.
Blood samples are used to analyze the pharmacokinetics of busulfan in patients undergoing hematopoietic stem cell transplantation for conditions such as Acute Leukemia, Chronic Leukemia, Lymphoproliferative Disease, Myeloproliferative Disease, and Immunodeficiency. The analysis involves measuring the levels of busulfan in the blood to evaluate its effectiveness and safety in these patients.
At a glance
| Generic name | Blood samples for PK |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors (PHASE1)
- Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (NA)
- Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations
- Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol (PHASE1)
- Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment (PHASE1)
- Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer (PHASE4)
- Study of DF1001 in Patients With Advanced Solid Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood samples for PK CI brief — competitive landscape report
- Blood samples for PK updates RSS · CI watch RSS
- Centre Hospitalier Universitaire de Saint Etienne portfolio CI
Frequently asked questions about Blood samples for PK
What is Blood samples for PK?
Who makes Blood samples for PK?
What development phase is Blood samples for PK in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing